The Munich Adrenaline Cancer Study

Status Completed

Clinical Trial Summary

Observational studies report associations between physical activity and survival in some types of adult cancer. In addition, some exercise-induced molecules such as catecholamines (e.g., adrenaline) are known to change cancer cell signalling, proliferation and have been linked to clinical outcomes such as survival. The aim of this study is to analyse changes in adrenaline concentration with a single high-intensity interval exercise intervention on a cycle ergometer in children and adolescents during treatment for cancer and to examine the feasibility of the study concept.

Clinical Trial Description

Exercise is generally recommended as an adjunct therapy for adult cancer patients as it counteracts the adverse effects of cancer and its treatment. According to epidemiological data, exercise is also associated with a reduced risk of tumour developement and an improval of survival in some tumours. However, the underlying mechanisms by which exercise affects tumour cells are poorly understood in adult cancer patients and mostly unknown in children. Recent studies demonstrate anti-cancer effects of exercise-induced adrenaline through natural killer cell mobilisation and Hippo signalling. In addition, several exercise-induced molecules such as catecholamines (e.g., adrenaline) are known to change cancer cell signalling, proliferation and have been linked to clinical outcomes such as survival. The aim of this pilot study is the analysation of exercise-induced changes in adrenaline concentration in childhood cancer patients and to show feasibility of the study concept. Following recruitment within the first and third cycle of chemotherapy and consent for study participation, all recruited patients perform a single high-intensity interval exercise intervention on a cycle ergometer. Intensity of the intervals is examined both subjectively via a scale for rate of perceived exertion and objectively via changes in lactate concentration pre- and post-exercise as well as heart rate monitoring. Blood samples are taken by trained personnel staff and prepared for processing (centrifuged, snap-frozen). Changes in adrenaline concentration are measured with a commercial ELISA kit. For further identification of metabolites that change with exercise, a non-biased mass spectrometry metabolomics analysis will be used. ;

Study Design

Related Conditions & MeSH terms

Childhood Cancer

Clinical Trial Details

NCT number	NCT04847908
Study type	Interventional
Source	Technische Universität München
Contact
Status	Completed
Phase	N/A
Start date	March 1, 2018
Completion date	May 31, 2021

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT04202094` - Fertility in Young Adults Who Did (Not) Store Testicular Tissue Before a Treatment Leading to Fertility Problems	N/A
Active, not recruiting	`NCT03336931` - PRecISion Medicine for Children With Cancer
Not yet recruiting	`NCT05048771` - Fertility and Temporality in Pediatric Oncology
Completed	`NCT05982379` - Motivation Program for Children With Cancer	N/A
Completed	`NCT04066218` - Sexual Function Screening in Childhood Cancer Survivors
Completed	`NCT03934060` - Strength Training and ADLs in Childhood Leukemia and Lymphoma Patients	N/A
Active, not recruiting	`NCT03938324` - Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions	N/A
Active, not recruiting	`NCT04032743` - Risk Factors and Treatment Outcome of Oncology Children Hospitalized in the Intensive Care Unit Due to Sepsis
Active, not recruiting	`NCT04328350` - Social Experiences of Adolescents and Young Adults With Cancer
Not yet recruiting	`NCT05457153` - Technology-Based Well-Being Process Program (WEBEPROP) for Children and Adolescents in Palliative Care	N/A
Recruiting	`NCT05641961` - Mobile App to Help Survivors of Childhood Cancer Navigate Long-Term Follow-Up Care	N/A
Completed	`NCT06179914` - Resilience Models in Adolescence and Youth With Cancer in Taiwan
Completed	`NCT03951246` - Cognitive and Motor Training in Pediatric Posterior Fossa Tumor Survivors	N/A
Not yet recruiting	`NCT04902313` - Cultivating Resilience in Oncology Practice	N/A
Completed	`NCT03160768` - Feasibility of Isolating P16 Expression
Recruiting	`NCT06053268` - Mindfulness Interventions to Improve Health Activation, Coping, and Stress Among Childhood Cancer Survivors	N/A
Recruiting	`NCT06411704` - Remote Exercise Video Adaptations to Maximize Physical Activity in Childhood Cancer
Withdrawn	`NCT02130934` - Cardiac 3D MRI in Pediatric Cancer Patients	N/A
Completed	`NCT02216604` - Exercise in Pediatric Cancer Patient Undergoing Anti-Cancer Treatment	N/A
Recruiting	`NCT03852758` - Green Exercise for Cancer - Creating Opportunities for Survivors	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

The Munich Adrenaline Cancer Study — MACS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms